227 related articles for article (PubMed ID: 26283460)
1. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
Nam HY; Lee HY; Park GC
Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
[TBL] [Abstract][Full Text] [Related]
2. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
5. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
Hsieh CJ; Wang PW
Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
Ryu YJ; Yoon JH
Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.
Yu Y; Zhang J; Lu G; Li T; Zhang Y; Yu N; Gao Y; Gao Y; Guo X
J Clin Endocrinol Metab; 2016 Apr; 101(4):1516-24. PubMed ID: 26866571
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.
Carvalho MS; Rosario PW; Mourão GF; Calsolari MR
Endocrine; 2017 Mar; 55(3):954-958. PubMed ID: 27878772
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.
Kuo SF; Chao TC; Chang HY; Hsueh C; Lin CL; Chiang KC; Chuang WY; Chen YC; Lin JD
Asian J Surg; 2017 May; 40(3):186-192. PubMed ID: 26553529
[TBL] [Abstract][Full Text] [Related]
13. Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study.
Jia X; Pang P; Wang L; Zhao L; Jiang L; Song Y; Fan X; Wang Y; Zhao S; Ba J; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Mu Y; Lyu Z
Front Endocrinol (Lausanne); 2020; 11():452. PubMed ID: 32760349
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
Ernaga-Lorea A; Hernández-Morhain MC; Anda-Apiñániz E; Pineda-Arribas JJ; Migueliz-Bermejo I; Eguílaz-Esparza N; Irigaray-Echarri A
Clin Transl Oncol; 2018 Jun; 20(6):740-744. PubMed ID: 29071517
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
Kim WW; Ha TK; Bae SK
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
[TBL] [Abstract][Full Text] [Related]
16. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy.
Côrtes MCS; Rosario PW; Mourão GF; Calsolari MR
Braz J Otorhinolaryngol; 2018; 84(4):448-452. PubMed ID: 28625809
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
[TBL] [Abstract][Full Text] [Related]
19. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
20. THE SIGNIFICANCE OF THYROGLOBULIN ANTIBODIES IN PAPILLARY THYROID CANCER.
Woeber KA
Endocr Pract; 2016 Sep; 22(9):1132-3. PubMed ID: 27295018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
